|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1993-10-6
|
|
pubmed:abstractText |
Septic shock is frequently complicated by a syndrome of disseminated intravascular coagulation (DIC). Numerous uncontrolled clinical studies have reported that antithrombin III (ATIII) substitution might prevent DIC and death in septic shock.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
882-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8365305-Antithrombin III,
pubmed-meshheading:8365305-Blood Transfusion,
pubmed-meshheading:8365305-Disseminated Intravascular Coagulation,
pubmed-meshheading:8365305-Double-Blind Method,
pubmed-meshheading:8365305-Female,
pubmed-meshheading:8365305-Humans,
pubmed-meshheading:8365305-Male,
pubmed-meshheading:8365305-Middle Aged,
pubmed-meshheading:8365305-Prospective Studies,
pubmed-meshheading:8365305-Shock, Septic
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
|
|
pubmed:affiliation |
Service de Réanimation Polyvalente, Hôpital B. CHRU Lille, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
